Cargando…

Retraction Note: MIR600HG sponges miR-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating RNF44

Detalles Bibliográficos
Autores principales: Liu, Xingguang, Zhao, Tengda, Yuan, Zhe, Ge, Shaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665371/
https://www.ncbi.nlm.nih.gov/pubmed/37993448
http://dx.doi.org/10.1038/s41420-023-01711-8
_version_ 1785148855394762752
author Liu, Xingguang
Zhao, Tengda
Yuan, Zhe
Ge, Shaohua
author_facet Liu, Xingguang
Zhao, Tengda
Yuan, Zhe
Ge, Shaohua
author_sort Liu, Xingguang
collection PubMed
description
format Online
Article
Text
id pubmed-10665371
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-106653712023-11-22 Retraction Note: MIR600HG sponges miR-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating RNF44 Liu, Xingguang Zhao, Tengda Yuan, Zhe Ge, Shaohua Cell Death Discov Retraction Note Nature Publishing Group UK 2023-11-22 /pmc/articles/PMC10665371/ /pubmed/37993448 http://dx.doi.org/10.1038/s41420-023-01711-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Retraction Note
Liu, Xingguang
Zhao, Tengda
Yuan, Zhe
Ge, Shaohua
Retraction Note: MIR600HG sponges miR-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating RNF44
title Retraction Note: MIR600HG sponges miR-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating RNF44
title_full Retraction Note: MIR600HG sponges miR-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating RNF44
title_fullStr Retraction Note: MIR600HG sponges miR-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating RNF44
title_full_unstemmed Retraction Note: MIR600HG sponges miR-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating RNF44
title_short Retraction Note: MIR600HG sponges miR-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating RNF44
title_sort retraction note: mir600hg sponges mir-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating rnf44
topic Retraction Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665371/
https://www.ncbi.nlm.nih.gov/pubmed/37993448
http://dx.doi.org/10.1038/s41420-023-01711-8
work_keys_str_mv AT liuxingguang retractionnotemir600hgspongesmir125a5ptoregulateglycometabolismandcisplatinresistanceoforalsquamouscellcarcinomacellsviamediatingrnf44
AT zhaotengda retractionnotemir600hgspongesmir125a5ptoregulateglycometabolismandcisplatinresistanceoforalsquamouscellcarcinomacellsviamediatingrnf44
AT yuanzhe retractionnotemir600hgspongesmir125a5ptoregulateglycometabolismandcisplatinresistanceoforalsquamouscellcarcinomacellsviamediatingrnf44
AT geshaohua retractionnotemir600hgspongesmir125a5ptoregulateglycometabolismandcisplatinresistanceoforalsquamouscellcarcinomacellsviamediatingrnf44